Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Transcode Therapeutics (RNAZ)
Squarespace, Inc. (SQSP)
Procore Technologies, Inc. (PCOR)
Oatly Group Ab (OTLY)
Ziprecruiter, Inc. (ZIP)
Priced IPO
Save Foods (SVFD)
Vera Therapeutics, Inc. (VERA)
Digital Brands Group, Inc. (DBGI)
Ipower Inc. (IPW)
Global-e Online Ltd. (GLBE)
Similarweb Ltd. (SMWB)
Flora Growth (FLGC)
Anebulo Pharmaceuticals (ANEB)
Bowman Consulting Group Ltd. (BWMN)
Onion Global Limited (OG)
Waterdrop Inc. (WDH)
Talaris Therapeutics, Inc. (TALS)
Valneva Se (VALN)
Five Star Bancorp (FSBC)
The Honest Company Inc. (HNST)
Alfi, Inc. (ALF)
Red Cat Holdings (RCAT)
Werewolf Therapeutics Inc. (HOWL)
Vaccitech Plc. (VACC)
Endeavor Group Holdings (EDR)
More companies

Recursion Pharmaceuticals, Inc. (RXRX)

Sector - Healthcare

Price chart

+17.89%
Return from IPO

Company News

IPO Profile

About company

Company Logo
They are a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to their mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what they believe is one of the world’s largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that they use to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate their programs. The combination of wet-lab biology and in silico tools in their closed-loop system differentiates them from others within the industry. Similarly, their balanced team of life scientists and computational and technical experts creates an environment where empirical data, statistical rigor, and creative thinking are brought to bear on their decisions. Every program at Recursion is a product of their Recursion OS. While they are advancing 37 programs, they highlight ten 'Notable Programs' that are key, near-term value drivers given their individual market opportunities and the validation they provide for each generation of the Recursion OS.
Industry
Biological Products (no Diagnostic Substances)
CEO CFO
Christopher Gibson Michael Secora
Employees Founded
216 2013

Contacts

Address: 41 S Rio Grande Street Salt Lake City, Ut 84101 (385) 269-0203

Telephone: (385) 269-0203)

Web page: http://www.recursionpharma.com

IPO information

First Trade Date 4/16/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 18
Shares Revised (MM) 24.2
Expected offer amount (MM) $306
Realized offer amount(MM) $435.6

Financial Data (last reporting year)

Market Cap (MM) $2650.47
Revenues (MM) $3.96
Net Income (Loss) (MM) $-87.01

Voting

What do you think will happen with the RXRX share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: Goldman Sachs

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
Goldman Sachs/ JP Morgan/ BofA Securities/ SVB Leerink/ Allen & Co
CO-Managers
KeyBanc Capital

Sector: Healthcare

Tweets about $RXRX

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats